This page contains the most important details of this project. If you find the information on this project inaccurate or inappropriate, please let us know by contacting us.
Submit Audition/Proposal on this Project
Rate this Project
Invitation Inbox
Project Main Details
Female voice needed for a corporate video
LTK63010301630X
This is a voice-over for a corporate video on innovation and innovators to be shown at an employee meeting. The script is not yet approved, but will be substantially similar to what is posted with this announcement (provided for your fee estimation purposes). Talent must have an in-house recording studio of excellent quality and the ability to phone patch in the director and deliver in electronic format (MP3/WAVE/AIFF). No post-production is required; you will just send the raw audio as recorded. Fee quoted should be buyout. Due to time constraints on delivery, you must be available to record the VO on Thursday or Friday (Nov 2 or 3).
Custom demos only, please. Be advised that, due to anticipated response volume, this request will only be open for approximately 24 hours.
We are a professional production company. We are pleasant to work with, organized, and professional. We're looking forward to hearing your custom demo.
Thanks for taking the time to respond.
Budget USD$250 - $499 Oct 30, 2006 19:25:03 (GMT -05:00) Eastern Time (US & Canada) Oct 31, 2006 00:00:00 (GMT -05:00) Eastern Time (US & Canada) No (click here to learn more about
)
Closed
54
53
0 direct invitation(s) have been sent by the voice seeker resulting in 0 audition(s) and/or proposal(s) so far.
Custom demos only, please. Be advised that, due to anticipated response volume, this request will only be open for approximately 24 hours.
We are a professional production company. We are pleasant to work with, organized, and professional. We're looking forward to hearing your custom demo.
Thanks for taking the time to respond.
Budget USD$250 - $499 Oct 30, 2006 19:25:03 (GMT -05:00) Eastern Time (US & Canada) Oct 31, 2006 00:00:00 (GMT -05:00) Eastern Time (US & Canada) No (click here to learn more about
)
Closed
54
53
0 direct invitation(s) have been sent by the voice seeker resulting in 0 audition(s) and/or proposal(s) so far.
Project Parameters
None
Flexible - USD 499
Videogames
Not defined
English - North American
Not defined
Middle Age Female
Not defined
There are no special pre-, post-, or production requirements for this project.
Not defined
Not defined
Script Details
Yes
Budget USD$250 - $499
[short 3-4 sentence introduction to be written]
In the first half of the 20th century, polio cast a long shadow over childhood.
Every year, tens of thousands of children were infected with the crippling disease, robbed of their health and their childhoods. Polio sufferers faced lives in leg braces and wheelchairs. Some even needed iron lungs to help their paralyzed chests breathe. The fear of this devastating disease terrorized everyone. Parents were afraid to send their children to community pools, to play with friends, to breathe the air in the sunshine.
Many researchers worked on a polio vaccine and contributed pieces of the puzzle. It was the son of Polish-Jewish immigrants, Jonas Salk, and his team at the University of Pittsburgh who first lifted this scourge from humankind.
Bucking the conventional wisdom that a polio vaccine would have to use live virus, Salk instead drew on his work studying influenza and succeeded in developing a killed virus vaccine that could immunize without infecting. Salk, labeled by rivals as a “kitchen chemist,” did not have a PhD and had no experience with polio, but he was quick, efficient and relentless in pursuing his idea that infection was not necessary to become immune.
He was also at ease in the public eye. Salk rejected his right to patent the vaccine, and thereby his ability to profit from its manufacture, because he wanted it to be as widely distributed as possible. He became the unofficial spokesman for the cause of vaccination and was awarded the Nobel Prize.
Salk founded the Salk Institute and continued to research and publish. When he died, he was working on a vaccine for the scourge of a new generation—AIDS.
Wilma Rudolph knew all about the pain of childhood diseases. Born prematurely at just 4 ½ pounds, she was a sickly child, afflicted with double pneumonia, scarlet fever, and polio. At six, she lost the use of her left leg and was fitted with leg braces. Doctors said she would never walk unassisted.
But her mother told her differently. She drove Wilma long distances to physical therapy. Rudolph’s 21 brothers and sisters massaged her leg daily and kept an eye out for adults so she could remove her braces and play like a regular kid. Rudolph fought off whooping cough, measles and chicken pox and threw off her leg braces for good at age 9.
No matter what came her way, Rudolph pressed on. She grew tall, became a basketball star, and ran lightning fast for Tennessee State University. She was the first American woman to win three gold medals in one Olympics. She tied the world record in the 100 and was the anchor leg on the world record relay team at the 1960 Rome Olympics.
Rudolph blazed a path not only on the track, but also in society. At her insistence, Rudolph’s homecoming after the Rome Olympics was the first integrated event in her hometown. Rudolph was beloved all over the world and became an American ambassador, using her positive attitude and soft-spoken grace to open doors for generations of African-American athletes who came after her.
For two recent Stanford electrical engineering graduates, a 1934 camping trip was the start of a lifelong friendship and a pivotal moment in the history of electronics. With $538 in cash and a used Sears-Roebuck drill press, the two friends went into business together in a shed. That shed became the birthplace of Silicon Valley. The men were Bill Hewlett and David Packard.
Their first product was an autooscillator, which was used to test sound equipment. Disney bought the machines and used them to test theaters that showed the groundbreaking Fantasia.
Government equipment needs for fighting World War II were a boon for the fledgling company, with profits funding new product development and construction of Hewlett-Packard’s first building.
Hewlett-Packard continued to innovate in both machine design and management style. HP produced signal generators, microwave devices, frequency counters, oscilloscopes, medical electronics, scientific calculators, and computing devices.
In the late 70s and early 80s, HP built on an industrial printing technology to create thermal inkjet printing—miniaturizing the inkjet process, controlling the ink flow, and packaging it as a personal printer that had better quality and quieter operation than existing dot matrix printers. In 1984, HP’s ThinkJet took the market by storm and wiped out the dot-matrix standard. Beyond revolutionizing office and home printing, inkjet technology is now used in scores of other applications, from direct mail addressing to fine art printing to point-of-sale receipts.
A self-described “daydreamer,” Sir James W. Black was an unassuming Scotsman from the coal fields of Fife. He was admittedly “manhandled” by a teacher into sitting for the entrance exam to St. Andrews University. He earned a scholarship that led to a brilliant pharmacology career, highlighted by seminal discoveries that launched two major drug families: beta blockers and histamine receptor blockers.
Black and his team thought differently. Rather than modify natural substances and test the effects, Black's logic-based analytical pharmacology approach sought to understand how cells communicate using messenger molecules. Then, he demonstrated that you could develop a molecule similar enough to the parent to allow binding, but without activating the receptor, thus blocking an undesirable effect. This principle revolutionized drug development.
Histamine receptor blockers, developed according to this methodology by Black, Mike Parsons, William Duncan, Graham Durant, John Emmett, and Robin Ganellin, have transformed the lives of millions of ulcer sufferers. This research culminated with the invention of cimetidine, known to the world as Tagamet.
Tagamet was the first clinically effective histamine H2-receptor antagonist. It became the top-selling prescription drug in many countries, and then reached a billion dollars a year in sales.
By blocking acid production, Tagamet relieved the pain of millions and spared untold numbers the trauma of surgery.
Winner of a Nobel Prize, James Black's work continues at the James Black Foundation, a non-profit which works to develop prototype drugs and is fully funded by Johnson & Johnson.
How will you overcome your obstacles? What story will you write? How will you be remembered? What legacy will you leave behind? How will the next generation of innovators stand on your shoulders?
Budget USD$250 - $499
[short 3-4 sentence introduction to be written]
In the first half of the 20th century, polio cast a long shadow over childhood.
Every year, tens of thousands of children were infected with the crippling disease, robbed of their health and their childhoods. Polio sufferers faced lives in leg braces and wheelchairs. Some even needed iron lungs to help their paralyzed chests breathe. The fear of this devastating disease terrorized everyone. Parents were afraid to send their children to community pools, to play with friends, to breathe the air in the sunshine.
Many researchers worked on a polio vaccine and contributed pieces of the puzzle. It was the son of Polish-Jewish immigrants, Jonas Salk, and his team at the University of Pittsburgh who first lifted this scourge from humankind.
[short 3-4 sentence introduction to be written]
In the first half of the 20th century, polio cast a long shadow over childhood.
Every year, tens of thousands of children were infected with the crippling disease, robbed of their health and their childhoods. Polio sufferers faced lives in leg braces and wheelchairs. Some even needed iron lungs to help their paralyzed chests breathe. The fear of this devastating disease terrorized everyone. Parents were afraid to send their children to community pools, to play with friends, to breathe the air in the sunshine.
Many researchers worked on a polio vaccine and contributed pieces of the puzzle. It was the son of Polish-Jewish immigrants, Jonas Salk, and his team at the University of Pittsburgh who first lifted this scourge from humankind.
Bucking the conventional wisdom that a polio vaccine would have to use live virus, Salk instead drew on his work studying influenza and succeeded in developing a killed virus vaccine that could immunize without infecting. Salk, labeled by rivals as a “kitchen chemist,” did not have a PhD and had no experience with polio, but he was quick, efficient and relentless in pursuing his idea that infection was not necessary to become immune.
He was also at ease in the public eye. Salk rejected his right to patent the vaccine, and thereby his ability to profit from its manufacture, because he wanted it to be as widely distributed as possible. He became the unofficial spokesman for the cause of vaccination and was awarded the Nobel Prize.
Salk founded the Salk Institute and continued to research and publish. When he died, he was working on a vaccine for the scourge of a new generation—AIDS.
Wilma Rudolph knew all about the pain of childhood diseases. Born prematurely at just 4 ½ pounds, she was a sickly child, afflicted with double pneumonia, scarlet fever, and polio. At six, she lost the use of her left leg and was fitted with leg braces. Doctors said she would never walk unassisted.
But her mother told her differently. She drove Wilma long distances to physical therapy. Rudolph’s 21 brothers and sisters massaged her leg daily and kept an eye out for adults so she could remove her braces and play like a regular kid. Rudolph fought off whooping cough, measles and chicken pox and threw off her leg braces for good at age 9.
No matter what came her way, Rudolph pressed on. She grew tall, became a basketball star, and ran lightning fast for Tennessee State University. She was the first American woman to win three gold medals in one Olympics. She tied the world record in the 100 and was the anchor leg on the world record relay team at the 1960 Rome Olympics.
Rudolph blazed a path not only on the track, but also in society. At her insistence, Rudolph’s homecoming after the Rome Olympics was the first integrated event in her hometown. Rudolph was beloved all over the world and became an American ambassador, using her positive attitude and soft-spoken grace to open doors for generations of African-American athletes who came after her.
For two recent Stanford electrical engineering graduates, a 1934 camping trip was the start of a lifelong friendship and a pivotal moment in the history of electronics. With $538 in cash and a used Sears-Roebuck drill press, the two friends went into business together in a shed. That shed became the birthplace of Silicon Valley. The men were Bill Hewlett and David Packard.
Their first product was an autooscillator, which was used to test sound equipment. Disney bought the machines and used them to test theaters that showed the groundbreaking Fantasia.
Government equipment needs for fighting World War II were a boon for the fledgling company, with profits funding new product development and construction of Hewlett-Packard’s first building.
Hewlett-Packard continued to innovate in both machine design and management style. HP produced signal generators, microwave devices, frequency counters, oscilloscopes, medical electronics, scientific calculators, and computing devices.
In the late 70s and early 80s, HP built on an industrial printing technology to create thermal inkjet printing—miniaturizing the inkjet process, controlling the ink flow, and packaging it as a personal printer that had better quality and quieter operation than existing dot matrix printers. In 1984, HP’s ThinkJet took the market by storm and wiped out the dot-matrix standard. Beyond revolutionizing office and home printing, inkjet technology is now used in scores of other applications, from direct mail addressing to fine art printing to point-of-sale receipts.
A self-described “daydreamer,” Sir James W. Black was an unassuming Scotsman from the coal fields of Fife. He was admittedly “manhandled” by a teacher into sitting for the entrance exam to St. Andrews University. He earned a scholarship that led to a brilliant pharmacology career, highlighted by seminal discoveries that launched two major drug families: beta blockers and histamine receptor blockers.
Black and his team thought differently. Rather than modify natural substances and test the effects, Black's logic-based analytical pharmacology approach sought to understand how cells communicate using messenger molecules. Then, he demonstrated that you could develop a molecule similar enough to the parent to allow binding, but without activating the receptor, thus blocking an undesirable effect. This principle revolutionized drug development.
Histamine receptor blockers, developed according to this methodology by Black, Mike Parsons, William Duncan, Graham Durant, John Emmett, and Robin Ganellin, have transformed the lives of millions of ulcer sufferers. This research culminated with the invention of cimetidine, known to the world as Tagamet.
Tagamet was the first clinically effective histamine H2-receptor antagonist. It became the top-selling prescription drug in many countries, and then reached a billion dollars a year in sales.
By blocking acid production, Tagamet relieved the pain of millions and spared untold numbers the trauma of surgery.
Winner of a Nobel Prize, James Black's work continues at the James Black Foundation, a non-profit which works to develop prototype drugs and is fully funded by Johnson & Johnson.
How will you overcome your obstacles? What story will you write? How will you be remembered? What legacy will you leave behind? How will the next generation of innovators stand on your shoulders?
Budget USD$250 - $499
[short 3-4 sentence introduction to be written]
In the first half of the 20th century, polio cast a long shadow over childhood.
Every year, tens of thousands of children were infected with the crippling disease, robbed of their health and their childhoods. Polio sufferers faced lives in leg braces and wheelchairs. Some even needed iron lungs to help their paralyzed chests breathe. The fear of this devastating disease terrorized everyone. Parents were afraid to send their children to community pools, to play with friends, to breathe the air in the sunshine.
Many researchers worked on a polio vaccine and contributed pieces of the puzzle. It was the son of Polish-Jewish immigrants, Jonas Salk, and his team at the University of Pittsburgh who first lifted this scourge from humankind.
Please note that you should only use the script or your recording of it for auditioning purposes. The script is property, unless otherwise specified, of the voice seeker and it is protected by international copyright laws.
Voice-Seeker Details
Voice123 Team Comments
Voice123 consultations with this voice seeker regarding this project and/or other projects by this voice seeker, via phone, chat, and/or email.
This project - phone.
Previous projects - phone.
This project - email or chat.
Previous projects - email or chat.
Corporate web site for this voice-seeker confirmed by Voice123
Note: Voice123 strives to establish the legitimacy of all projects posted. However, Voice123 subscribers and users are responsible for confirming information stated by prospective voice seekers, agents and/or clients. Voice123 subscribers and users assume all liability for use of any information found through Voice123, LLC, or any of its publications.
